Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain Metastases

Lignende værker

• Challenges in the delivery of therapies to melanoma brain metastases
  af: Gampa, Gautham, et al.
  Udgivet: (2016)
• Factors Influencing the CNS Distribution of a Novel MEK-1/2 Inhibitor: Implications for Combination Therapy for Melanoma Brain Metastases
  af: Vaidhyanathan, Shruthi, et al.
  Udgivet: (2014)
• Mechanisms Limiting Distribution of the Threonine-Protein Kinase B-RaF(V600E) Inhibitor Dabrafenib to the Brain: Implications for the Treatment of Melanoma Brain Metastases
  af: Mittapalli, Rajendar K., et al.
  Udgivet: (2013)
• Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on the Brain Distribution of a Novel BRAF Inhibitor: Vemurafenib (PLX4032)
  af: Mittapalli, Rajendar K., et al.
  Udgivet: (2012)
• Efflux Transporters at the Blood-Brain Barrier Limit Delivery and Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib (PD-0332991) in an Orthotopic Brain Tumor Model
  af: Parrish, Karen E., et al.
  Udgivet: (2015)